Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2)
ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Human
VHH-hFc (IgG1)
3-2A2-4
Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2)
ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Human
IgG1, kappa
H014
Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2)
ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Human
IgG1, kappa
COVA1-16
Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2)
ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Human
IgG1, kappa
CV2-75
Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2)
ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Human
IgG1, kappa
6D60
Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2)
ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Human
IgG1, kappa
BG10-19
SARS-CoV-2(2019-nCoV)
ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Human
IgG1-kappa
S2M11
SARS-CoV-2 (2019-nCoV)
ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Human
IgG
47D11
SARS-CoV-2 (2019-nCoV)
ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Human
IgG
CT P63
SARS-CoV-2 (2019-nCoV)
ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Human
IgG
CT P66